Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 791

1.

Comparison of multi-walled carbon nanotube and nitrogen-doped multi-walled carbon nanotube effects on lung function and airway reactivity in rats.

Russ KA, Thompson JA, Kashon M, Porter DW, Friend SA, McKinney W, Fedan JS.

Toxicol Appl Pharmacol. 2018 Nov 10. pii: S0041-008X(18)30501-5. doi: 10.1016/j.taap.2018.11.004. [Epub ahead of print]

PMID:
30423287
2.

Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration.

Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM.

BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614. No abstract available.

3.

Guidelines of care for the management of primary cutaneous melanoma.

Work Group, Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, Guild V, Grant-Kels JM, Halpern AC, Johnson TM, Sober AJ, Thompson JA, Wisco OJ, Wyatt S, Hu S, Lamina T.

J Am Acad Dermatol. 2018 Oct 29. pii: S0190-9622(18)32588-X. doi: 10.1016/j.jaad.2018.08.055. [Epub ahead of print]

PMID:
30392755
4.

Method for localizing intraoperative recordings from deep brain stimulation surgery using post-operative structural MRI.

Winter M, Costabile JD, Abosch A, Thompson JA.

Neuroimage Clin. 2018 Oct 16;20:1123-1128. doi: 10.1016/j.nicl.2018.10.016. [Epub ahead of print]

5.

Association of MRI Measurements with Cognitive Outcomes After STN-DBS in Parkinson's Disease.

Weinkle LJ, Hoyt B, Thompson JA, Sillau S, Tanabe J, Honce J, Klepitskaya O.

Mov Disord Clin Pract. 2018 Jul 28;5(4):417-426. doi: 10.1002/mdc3.12643. eCollection 2018 Jul-Aug.

PMID:
30363383
6.

Constructing Kinetically Controlled Denaturation Isotherms of Folded Proteins Using Denaturant-Pulse Chaperonin Binding.

O'Neil PT, Machen AJ, Thompson JA, Wang W, Hoang QQ, Baldwin MR, Khar KR, Karanicolas J, Fisher MT.

Methods Mol Biol. 2019;1873:293-304. doi: 10.1007/978-1-4939-8820-4_19.

PMID:
30341618
7.

Salicylate toxicity after undetectable serum salicylate concentration: a retrospective cohort study.

Moss MJ, Fisher JA, Kenny TA, Palmer AC, Thompson JA, Wolfer H, Hendrickson RG.

Clin Toxicol (Phila). 2018 Oct 11:1-4. doi: 10.1080/15563650.2018.1502442. [Epub ahead of print]

PMID:
30306804
8.

Broad, Multi-Year Sampling Effort Highlights Complex Dynamics of the Tick-Borne Pathogen Ehrlichia chaffeensis (Rickettsiales: Anaplasmatacae).

Simpson DT, Teague MS, Weeks JK, Lewis AD, D'Addio PM, Moore JD, Thompson JA, Harris AC, Cannella RT, Kaup BZ, Kerscher O, Leu M.

J Med Entomol. 2018 Oct 6. doi: 10.1093/jme/tjy171. [Epub ahead of print]

PMID:
30295826
9.

Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2018 Oct 3. doi: 10.1002/cncr.31719. [Epub ahead of print] Review.

PMID:
30281145
10.

Development of High-Throughput Clinical Testing of RPGR ORF15 Using a Large Inherited Retinal Dystrophy Cohort.

Chiang JPW, Lamey TM, Wang NK, Duan J, Zhou W, McLaren TL, Thompson JA, Ruddle J, De Roach JN.

Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4434-4440. doi: 10.1167/iovs.18-24555.

PMID:
30193314
11.

Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report.

Appelbaum J, Wells D, Hiatt JB, Steinbach G, Stewart FM, Thomas H, Nghiem P, Kapur RP, Thompson JA, Bhatia S.

J Immunother Cancer. 2018 Aug 31;6(1):82. doi: 10.1186/s40425-018-0396-9.

12.

Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.

Zhang X, Zhang D, Chen SC, Lamey T, Thompson JA, McLaren T, De Roach JN, Chen FK, McLenachan S.

Stem Cell Res. 2018 Aug;31:147-151. doi: 10.1016/j.scr.2018.08.001. Epub 2018 Aug 2.

13.

Maternal uniparental isodisomy of chromosome 6 unmasks a novel variant in TULP1 in a patient with early onset retinal dystrophy.

Souzeau E, Thompson JA, McLaren TL, De Roach JN, Barnett CP, Lamey TM, Craig JE.

Mol Vis. 2018 Jul 21;24:478-484. eCollection 2018.

14.

Pan-Cancer Analysis Reveals Differential Susceptibility of Bidirectional Gene Promoters to DNA Methylation, Somatic Mutations, and Copy Number Alterations.

Thompson JA, Christensen BC, Marsit CJ.

Int J Mol Sci. 2018 Aug 5;19(8). pii: E2296. doi: 10.3390/ijms19082296.

15.

Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.

Thompson JA, Kityo C, Dunn D, Hoppe A, Ndashimye E, Hakim J, Kambugu A, van Oosterhout JJ, Arribas J, Mugyenyi P, Walker AS, Paton NI; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team.

Clin Infect Dis. 2018 Jul 28. doi: 10.1093/cid/ciy589. [Epub ahead of print]

PMID:
30060027
16.

Effects of multidisciplinary therapy on physical function in Huntington's disease.

Cruickshank TM, Reyes AP, Penailillo LE, Pulverenti T, Bartlett DM, Zaenker P, Blazevich AJ, Newton RU, Thompson JA, Lo J, Ziman MR.

Acta Neurol Scand. 2018 Dec;138(6):500-507. doi: 10.1111/ane.13002. Epub 2018 Jul 30.

PMID:
30058184
17.

Panniculitis in a patient with pathologic complete response to talimogene laherparepvec treatment for recurrent, in-transit melanoma.

Long TH, Shinohara MM, Argenyi ZB, Thompson JA, Gardner JM.

J Cutan Pathol. 2018 Nov;45(11):864-868. doi: 10.1111/cup.13332. Epub 2018 Aug 22.

PMID:
30054925
18.

Mortality and costs associated with alcoholic hepatitis: A claims analysis of a commercially insured population.

Thompson JA, Martinson N, Martinson M.

Alcohol. 2018 Sep;71:57-63. doi: 10.1016/j.alcohol.2018.02.003. Epub 2018 Mar 2.

19.

Reply to D.L. Kimpel et al.

Suarez-Almazor ME, Thompson JA, Brahmer JR.

J Clin Oncol. 2018 Sep 10;36(26):2744. doi: 10.1200/JCO.2018.79.1798. Epub 2018 Jul 18. No abstract available.

PMID:
30020818
20.

Grain zinc concentrations differ among Brazilian wheat genotypes and respond to zinc and nitrogen supply.

Pascoalino JAL, Thompson JA, Wright G, Franco FA, Scheeren PL, Pauletti V, Moraes MF, White PJ.

PLoS One. 2018 Jul 10;13(7):e0199464. doi: 10.1371/journal.pone.0199464. eCollection 2018.

21.

The lifelong impact of fetal growth restriction on cardiac development.

Masoumy EP, Sawyer AA, Sharma S, Patel JA, Gordon PMK, Regnault TRH, Matushewski B, Weintraub NL, Richardson B, Thompson JA, Stansfield BK.

Pediatr Res. 2018 Jun 2. doi: 10.1038/s41390-018-0069-x. [Epub ahead of print]

PMID:
29967522
22.

Neuronal integrity and complement control synaptic material clearance by microglia after CNS injury.

Norris GT, Smirnov I, Filiano AJ, Shadowen HM, Cody KR, Thompson JA, Harris TH, Gaultier A, Overall CC, Kipnis J.

J Exp Med. 2018 Jul 2;215(7):1789-1801. doi: 10.1084/jem.20172244. Epub 2018 Jun 25.

PMID:
29941548
23.

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Dreno B, Thompson JF, Smithers BM, Santinami M, Jouary T, Gutzmer R, Levchenko E, Rutkowski P, Grob JJ, Korovin S, Drucis K, Grange F, Machet L, Hersey P, Krajsova I, Testori A, Conry R, Guillot B, Kruit WHJ, Demidov L, Thompson JA, Bondarenko I, Jaroszek J, Puig S, Cinat G, Hauschild A, Goeman JJ, van Houwelingen HC, Ulloa-Montoya F, Callegaro A, Dizier B, Spiessens B, Debois M, Brichard VG, Louahed J, Therasse P, Debruyne C, Kirkwood JM.

Lancet Oncol. 2018 Jul;19(7):916-929. doi: 10.1016/S1470-2045(18)30254-7. Epub 2018 Jun 13.

PMID:
29908991
24.

Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.

Thompson JA, Motzer RJ, Molina AM, Choueiri TK, Heath EI, Redman BG, Sangha RS, Ernst DS, Pili R, Kim SK, Reyno L, Wiseman A, Trave F, Anand B, Morrison K, DoƱate F, Kollmannsberger CK.

Clin Cancer Res. 2018 Sep 15;24(18):4399-4406. doi: 10.1158/1078-0432.CCR-18-0481. Epub 2018 May 30.

PMID:
29848572
25.

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.

Sullivan RJ, Atkins MB, Kirkwood JM, Agarwala SS, Clark JI, Ernstoff MS, Fecher L, Gajewski TF, Gastman B, Lawson DH, Lutzky J, McDermott DF, Margolin KA, Mehnert JM, Pavlick AC, Richards JM, Rubin KM, Sharfman W, Silverstein S, Slingluff CL Jr, Sondak VK, Tarhini AA, Thompson JA, Urba WJ, White RL, Whitman ED, Hodi FS, Kaufman HL.

J Immunother Cancer. 2018 May 30;6(1):44. doi: 10.1186/s40425-018-0362-6.

26.

New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity.

Thompson JA.

J Natl Compr Canc Netw. 2018 May;16(5S):594-596. doi: 10.6004/jnccn.2018.0047.

PMID:
29784734
27.

Semi-automated application for estimating subthalamic nucleus boundaries and optimal target selection for deep brain stimulation implantation surgery.

Thompson JA, Oukal S, Bergman H, Ojemann S, Hebb AO, Hanrahan S, Israel Z, Abosch A.

J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.12.JNS171964. [Epub ahead of print]

PMID:
29775152
28.

Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.

Zhang X, Zhang D, Chen SC, Lamey T, Thompson JA, McLaren T, De Roach JN, Chen FK, McLenachan S.

Stem Cell Res. 2018 May;29:245-249. doi: 10.1016/j.scr.2018.04.014. Epub 2018 May 1.

29.

Modular auditory decision-making behavioral task designed for intraoperative use in humans.

Tekriwal A, Felsen G, Thompson JA.

J Neurosci Methods. 2018 Jul 1;304:162-167. doi: 10.1016/j.jneumeth.2018.05.004. Epub 2018 May 7.

PMID:
29746889
30.

A Mini-Review: Leber Congenital Amaurosis: Identification of Disease-Causing Variants and Personalised Therapies.

Thompson JA, De Roach JN, McLaren TL, Lamey TM.

Adv Exp Med Biol. 2018;1074:265-271. doi: 10.1007/978-3-319-75402-4_32.

PMID:
29721952
31.

Robust analysis of stepped wedge trials using cluster-level summaries within periods.

Thompson JA, Davey C, Fielding K, Hargreaves JR, Hayes RJ.

Stat Med. 2018 Jul 20;37(16):2487-2500. doi: 10.1002/sim.7668. Epub 2018 Apr 10.

33.

The Tentorial Bridge to Deep Skull Base Exposure: Anatomic Morphometric Study.

Vasquez CA, Thompson JA, Youssef AS.

World Neurosurg. 2018 Jun;114:e588-e596. doi: 10.1016/j.wneu.2018.03.037. Epub 2018 Mar 16.

PMID:
29551719
34.

Nonspecialty Nurse Education: Evaluation of the Oncology Intensives Initiative, an Oncology Curriculum to Improve Patient Care

Bagley KA, Dunn SE, Chuang EY, Dorr VJ, Thompson JA, Smith SK.

Clin J Oncol Nurs. 2018 Apr 1;22(2):E44-E51. doi: 10.1188/18.CJON.E44-E51.

PMID:
29547596
35.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Brahmer JR, Lacchetti C, Thompson JA.

J Oncol Pract. 2018 Apr;14(4):247-249. doi: 10.1200/JOP.18.00005. Epub 2018 Mar 8. No abstract available.

PMID:
29517954
36.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA; National Comprehensive Cancer Network.

J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.

PMID:
29442540
37.

Retrospective Chart Review of the Triage Algorithm for Psychiatric Screening (TAPS) for Patients Who Present to Emergency Departments With Psychiatric Chief Complaints.

Schieferle Uhlenbrock J, Hudson J, Prewitt J, Thompson JA, Pereira K.

J Emerg Nurs. 2018 Sep;44(5):459-465. doi: 10.1016/j.jen.2017.12.008. Epub 2018 Jan 19.

PMID:
29370946
38.

Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.

Veatch JR, Lee SM, Fitzgibbon M, Chow IT, Jesernig B, Schmitt T, Kong YY, Kargl J, Houghton AM, Thompson JA, McIntosh M, Kwok WW, Riddell SR.

J Clin Invest. 2018 Apr 2;128(4):1563-1568. doi: 10.1172/JCI98689. Epub 2018 Mar 12.

39.

Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study.

Atkins MB, Hodi FS, Thompson JA, McDermott DF, Hwu WJ, Lawrence DP, Dawson NA, Wong DJ, Bhatia S, James M, Jain L, Robey S, Shu X, Homet Moreno B, Perini RF, Choueiri TK, Ribas A.

Clin Cancer Res. 2018 Apr 15;24(8):1805-1815. doi: 10.1158/1078-0432.CCR-17-3436. Epub 2018 Jan 22.

PMID:
29358500
40.

Ophthalmic Complications Following Acoustic Neuroma Resection.

Gange WS, Kirchner ID, Thompson JA, Hill J, Grahnke K, Ibrahim T, Leonetti JP, Anderson DE, Bouchard CS.

Oper Neurosurg (Hagerstown). 2018 Jan 1;14(1):58-65. doi: 10.1093/ons/opx071.

PMID:
29253289
41.

Approaches to neuromodulation for schizophrenia.

Gault JM, Davis R, Cascella NG, Saks ER, Corripio-Collado I, Anderson WS, Olincy A, Thompson JA, Pomarol-Clotet E, Sawa A, Daskalakis ZJ, Lipsman N, Abosch A.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):777-787. doi: 10.1136/jnnp-2017-316946. Epub 2017 Dec 14. Review.

PMID:
29242310
42.

A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors.

Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HEK, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC, Cheever MA, Streicher H, Creekmore SP, Waldmann TA, Conlon KC.

Clin Cancer Res. 2018 Apr 1;24(7):1525-1535. doi: 10.1158/1078-0432.CCR-17-2451. Epub 2017 Dec 4.

PMID:
29203590
43.

The genetic profile of Leber congenital amaurosis in an Australian cohort.

Thompson JA, De Roach JN, McLaren TL, Montgomery HE, Hoffmann LH, Campbell IR, Chen FK, Mackey DA, Lamey TM.

Mol Genet Genomic Med. 2017 Nov;5(6):652-667. doi: 10.1002/mgg3.321. Epub 2017 Aug 22.

44.

Global and Targeted Pathway Impact of Gliomas on White Matter Integrity Based on Lobar Localization.

Ormond DR, D'Souza S, Thompson JA.

Cureus. 2017 Sep 7;9(9):e1660. doi: 10.7759/cureus.1660.

45.

Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.

Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, Harms KL, Thompson JA, Bhatia S, Stang A, Nghiem P.

J Am Acad Dermatol. 2018 Mar;78(3):457-463.e2. doi: 10.1016/j.jaad.2017.10.028. Epub 2017 Nov 2.

PMID:
29102486
46.

Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy.

Brown MG, Drees C, Nagae LM, Thompson JA, Ojemann S, Abosch A.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):425-433. doi: 10.1136/jnnp-2017-316003. Epub 2017 Oct 30. Review.

PMID:
29084870
47.

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.

Hoppe A, Giuliano M, Lugemwa A, Thompson JA, Floridia M, Walker AS, Senoga I, Abwola MC, Pirillo MF, Kityo CM, Arenas-Pinto A, Paton NI; EARNEST Trial Team.

Antivir Ther. 2018;23(2):191-195. doi: 10.3851/IMP3200.

48.

Sample Size Calculations for Population Size Estimation Studies Using Multiplier Methods With Respondent-Driven Sampling Surveys.

Fearon E, Chabata ST, Thompson JA, Cowan FM, Hargreaves JR.

JMIR Public Health Surveill. 2017 Sep 14;3(3):e59. doi: 10.2196/publichealth.7909.

49.

Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus.

Thompson JA, Tekriwal A, Felsen G, Ozturk M, Telkes I, Wu J, Ince NF, Abosch A.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):95-104. doi: 10.1136/jnnp-2017-316115. Epub 2017 Sep 2.

PMID:
28866626
50.

The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.

Thompson JA, Fielding K, Hargreaves J, Copas A.

Clin Trials. 2017 Dec;14(6):639-647. doi: 10.1177/1740774517723921. Epub 2017 Aug 10.

Supplemental Content

Loading ...
Support Center